Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Coronary artery disease concomitant with chronic obstructive pulmonary disease

Title: Coronary artery disease concomitant with chronic obstructive pulmonary disease
Authors: Sara Roversi; Pietro Roversi; Giuseppe Spadafora; ROSSI, Rosario; FABBRI, Leonardo
Contributors: Sara, Roversi; Pietro, Roversi; Giuseppe, Spadafora; Rossi, Rosario; Fabbri, Leonardo
Publication Year: 2014
Collection: Archivio della ricerca dell'Università di Modena e Reggio Emilia (Unimore: IRIS)
Subject Terms: Ageing; Chronic bronchiti; Ischaemic heart disease; Multimorbidity; Respiratory system; Smoking
Description: BackgroundNumerous epidemiologic studies have linked the presence of chronic obstructive pulmonary disease (COPD) to coronary artery disease (CAD). However, prevalence, pathological processes, clinical manifestations and therapy are still debated, as progress towards uncovering the link between these two disorders has been hindered by the complex nature of multimorbidity. MethodsArticles targeting CAD in patients with COPD were identified from the searches of MEDLINE and EMBASE databases in July 2013. Three authors reviewed available evidence, focusing on the latest development on disease prevalence, pathogenesis, clinical manifestations and therapeutic strategies. Both clinical trial and previous reviews have been included in this work. ResultsThe most accredited hypothesis asserts that the main common risk factors, that is, cigarette smoke and ageing, elicit a chronic low-grade systemic inflammatory response, which affects both cardiovascular endothelial cells and airways/lung parenchyma. The development of CAD in patients with COPD potentiates the morbidity of COPD, leading to increased hospitalizations, mortality and health costs. Moreover, correct diagnosis is challenging and therapies are not clearly defined. ConclusionsEvidence from recently published articles highlights the importance of multimorbidity in patient management and future research. Moreover, many authors emphasize the importance of low-grade systemic inflammation as a common pathological mechanism and a possible future therapeutic target
Document Type: article in journal/newspaper
File Description: STAMPA
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/24164255; info:eu-repo/semantics/altIdentifier/wos/WOS:000328543100012; volume:44; issue:1; firstpage:93; lastpage:102; numberofpages:10; journal:EUROPEAN JOURNAL OF CLINICAL INVESTIGATION; https://hdl.handle.net/11380/1001516
DOI: 10.1111/eci.12181
Availability: https://hdl.handle.net/11380/1001516; https://doi.org/10.1111/eci.12181
Rights: info:eu-repo/semantics/closedAccess
Accession Number: edsbas.DF30D2E2
Database: BASE